Canadian firm sees positive signs in COVID-19 vaccine trial, says courted to move production out of country – CTV

May 12, 2021

TORONTO — A Canadian drugmaker has posted promising Phase 1 trial results for its own COVID-19 vaccine, but is threatening to move its future trials and production out of the country if it doesn’t receive further support from the federal government.

On Wednesday, Calgary-based Providence Therapeutics released results from its Phase 1 trials of 60 participants aged 18-64 that show “strong virus neutralization capability” with no serious side-effects reported, according to a news release.

Participants in the Phase 1 trial were given either a placebo or Providence’s vaccine in one of three dose sizes. After 28 days, participants given any of the vaccine sizes showed COVID-19 antibodies, while all doses showed 100 per cent COVID-19 “blocking activity” after 42 days.

Read more: https://www.ctvnews.ca/health/coronavirus/canadian-firm-sees-positive-signs-in-covid-19-vaccine-trial-says-courted-to-move-production-out-of-country-1.5424076

NationTalk Partners & Sponsors Learn More